ArticleEndocrine, metabolic & immune disorders drug targets2025
Abnormal Elevation of the Expression of Costimulatory Molecule CD226 in Graves' Disease: Two Cross-Sectional Studies.
Zhaowei Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.